Arca Biopharma | ABIO - Market Capitalization


Arca Biopharma reported $1.47B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 39M 17M Sep/2026
Amgen USD 247.94B 20.06B Nov/2026
Arca Biopharma USD 2.43B 963M Mar/2026
Biogen USD 33.38B 1.48B Sep/2026
Brainstorm Cell Therapeutics USD 11M 3M Mar/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cipla INR 1.09T 96.42B Sep/2026
Clal Biotechnology ILS 52.36M 2.09M Mar/2025
Compugen USD 564.53M 41.47M Nov/2026
CSL USD 55.89B 20.42B Dec/2025
Cytokinetics USD 7.51B 1.66B Nov/2026
Daiichi Sankyo JPY 5.22T 356.74B Sep/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Laboratory Of America USD 24.99B 2.03B Sep/2026
Otsuka Holdings JPY 6.08T 213B Sep/2026
Pfizer USD 169.88B 6.47B Nov/2026
United Therapeutics USD 28.64B 5.4B Nov/2026